{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:39:20Z","timestamp":1760647160727,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00403-020-02040-x","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T11:04:05Z","timestamp":1581073445000},"page":"501-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hidradenitis suppurativa and pemphigus: a cross-sectional study"],"prefix":"10.1007","volume":"312","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-260X","authenticated-orcid":false,"given":"Virginia A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1612-3887","authenticated-orcid":false,"given":"Payal M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-5393","authenticated-orcid":false,"given":"Frederick T.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2906-2454","authenticated-orcid":false,"given":"Kyle T.","family":"Amber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"2040_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fmed.2018.00159","volume":"5","author":"K Kridin","year":"2018","unstructured":"Kridin K, Khamaisi M, Comaneshter D, Batat E, Cohen AD (2018) Autoimmune thyroid diseases and thyroid cancer in pemphigus: a big data analysis. Front Med (Lausanne) 5:159","journal-title":"Front Med (Lausanne)"},{"issue":"10201","key":"2040_CR2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","volume":"394","author":"E Schmidt","year":"2019","unstructured":"Schmidt E, Kasperkiewicz M, Joly P (2019) Pemphigus. Lancet 394(10201):882\u2013894","journal-title":"Lancet"},{"key":"2040_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3389\/fimmu.2018.01190","volume":"9","author":"KT Amber","year":"2018","unstructured":"Amber KT, Valdebran M, Grando SA (2018) Non-desmoglein antibodies in patients with pemphigus vulgaris. Front Immunol 9:1190. https:\/\/doi.org\/10.3389\/fimmu.2018.01190","journal-title":"Front Immunol"},{"key":"2040_CR4","doi-asserted-by":"crossref","unstructured":"Di Zenzo G, Amber KT, Sayar BS, M\u00fcller EJ, Borradori L, editors (2016) Immune response in pemphigus and beyond: progresses and emerging concepts. Seminars in immunopathology, Springer.","DOI":"10.1007\/s00281-015-0541-1"},{"issue":"2","key":"2040_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","volume":"66","author":"K Kridin","year":"2018","unstructured":"Kridin K (2018) Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res 66(2):255\u2013270","journal-title":"Immunol Res"},{"issue":"6","key":"2040_CR6","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/bjd.14463","volume":"174","author":"DY Hsu","year":"2016","unstructured":"Hsu DY, Brieva J, Sinha AA, Langan SM, Silverberg JI (2016) Comorbidities and inpatient mortality for pemphigus in the USA. Br J Dermatol. 174(6):1290\u20131298","journal-title":"Br J Dermatol."},{"issue":"6","key":"2040_CR7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/ced.12634","volume":"40","author":"K Heelan","year":"2015","unstructured":"Heelan K, Mahar AL, Walsh S, Shear NH (2015) Pemphigus and associated comorbidities: a cross-sectional study. Clin Exp Dermatol 40(6):593\u2013599","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"2040_CR8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","volume":"18","author":"K Manthiram","year":"2017","unstructured":"Manthiram K, Zhou Q, Aksentijevich I, Kastner DL (2017) The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol 18(8):832\u2013842","journal-title":"Nat Immunol"},{"issue":"5","key":"2040_CR9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1590\/abd1806-4841.20142930","volume":"89","author":"MV Ambiel","year":"2014","unstructured":"Ambiel MV, Roselino AM (2014) Prevalence of metabolic syndrome and its components in a Brazilian sample of pemphigus patients. An Bras Dermatol 89(5):752\u2013756","journal-title":"An Bras Dermatol"},{"issue":"12","key":"2040_CR10","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/00365521.2017.1380839","volume":"52","author":"K Kridin","year":"2017","unstructured":"Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD (2017) Ulcerative colitis associated with pemphigus: a population-based large-scale study. Scand J Gastroenterol 52(12):1360\u20131364","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"2040_CR11","first-page":"425","volume":"66","author":"K Kridin","year":"2018","unstructured":"Kridin K, Amber K, Khamaisi M, Comaneshter D, Batat E, Cohen AD (2018) Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A Popul Based Study Immunol Res 66(3):425\u2013430","journal-title":"A Popul Based Study Immunol Res"},{"issue":"3 Suppl 2","key":"2040_CR12","first-page":"8","volume":"153","author":"L Pescitelli","year":"2018","unstructured":"Pescitelli L, Ricceri F, Prignano F (2018) Hidradenitis suppurativa and associated diseases. G Ital Dermatol Venereol 153(3 Suppl 2):8\u201317","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"2040_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jdv.14517","volume":"32","author":"E Dauden","year":"2018","unstructured":"Dauden E, Lazaro P, Aguilar MD, Blasco AJ, Suarez C, Marin I et al (2018) Recommendations for the management of comorbidity in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 32(1):129\u2013144","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"2040_CR14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","volume":"71","author":"J Shlyankevich","year":"2014","unstructured":"Shlyankevich J, Chen AJ, Kim GE, Kimball AB (2014) Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol 71(6):1144\u20131150","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2040_CR15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","volume":"60","author":"A Alikhan","year":"2009","unstructured":"Alikhan A, Lynch PJ, Eisen DB (2009) Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 60(4):539\u2013561 quiz 62-3","journal-title":"J Am Acad Dermatol."},{"issue":"5","key":"2040_CR16","doi-asserted-by":"crossref","first-page":"e13003","DOI":"10.1111\/dth.13003","volume":"32","author":"S Vural","year":"2019","unstructured":"Vural S, Gundogdu M, Akay BN, Boyvat A, Erdem C, Kocyigit P, et al. (2019) Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy. Dermatol Ther 32(5):e13003","journal-title":"Dermatol Ther"},{"issue":"1","key":"2040_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.2006.07556.x","volume":"156","author":"E Giamarellos-Bourboulis","year":"2007","unstructured":"Giamarellos-Bourboulis E, Antonopoulou A, Petropoulou C, Mouktaroudi M, Spyridaki E, Baziaka F et al (2007) Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 156(1):51\u201356","journal-title":"Br J Dermatol"},{"issue":"2","key":"2040_CR18","first-page":"413","volume":"179","author":"T Kanni","year":"2018","unstructured":"Kanni T, Zenker O, Habel M, Riedemann N, Giamarellos-Bourboulis E (2018) Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis? Br J Dermatol 179(2):413\u2013419","journal-title":"Br J Dermatol"},{"issue":"5 Suppl 1","key":"2040_CR19","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","volume":"73","author":"JJ Kohorst","year":"2015","unstructured":"Kohorst JJ, Kimball AB, Davis MD (2015) Systemic associations of hidradenitis suppurativa. J Am Acad Dermatol 73(5 Suppl 1):S27\u201335","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2040_CR20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12026-018-9031-6","volume":"67","author":"K Kridin","year":"2019","unstructured":"Kridin K, Kridin M, Shalom G, Cohen AD (2019) The coexistence of pemphigus and psoriasis: a systematic review and meta-analysis. Immunol Res 67(1):134\u2013141","journal-title":"Immunol Res"},{"issue":"6","key":"2040_CR21","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaad.2017.07.007","volume":"77","author":"K Kridin","year":"2017","unstructured":"Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD (2017) Association between pemphigus and psoriasis: a population-based large-scale study. J Am Acad Dermatol 77(6):1174\u20131175","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2040_CR22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjd.15939","volume":"178","author":"A Garg","year":"2018","unstructured":"Garg A, Papagermanos V, Midura M, Strunk A (2018) Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the USA. Br J Dermatol. 178(3):709\u2013714","journal-title":"Br J Dermatol."},{"issue":"6","key":"2040_CR23","first-page":"404","volume":"3","author":"G Rennert","year":"2001","unstructured":"Rennert G, Peterburg Y (2001) Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 3(6):404\u2013408","journal-title":"Isr Med Assoc J"},{"issue":"3","key":"2040_CR24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/ced.12731","volume":"41","author":"M Utrera-Busquets","year":"2016","unstructured":"Utrera-Busquets M, Romero-Mat\u00e9 A, Casta\u00f1o \u00c1, Alegre L, Garc\u00eda-Donoso C, Borbujo J (2016) Severe hidradenitis suppurativa complicated by renal AA amyloidosis. Clin Exp Dermatol 41(3):287\u2013289","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"2040_CR25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jdcr.2019.02.026","volume":"5","author":"M Iannone","year":"2019","unstructured":"Iannone M, Oranges T, Chiricozzi A, De Tata V, Romanelli M, Dini V (2019) Potential role of serum amyloid A in hidradenitis suppurativa. JAAD Case Rep 5(5):406","journal-title":"JAAD Case Rep"},{"key":"2040_CR26","doi-asserted-by":"crossref","first-page":"i969","DOI":"10.1136\/bmj.i969","volume":"352","author":"N Pearce","year":"2016","unstructured":"Pearce N (2016) Analysis of matched case-control studies. BMJ 352:i969","journal-title":"BMJ"},{"issue":"7","key":"2040_CR27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bpobgyn.2014.07.012","volume":"28","author":"LJ Margesson","year":"2014","unstructured":"Margesson LJ, Danby FW (2014) Hidradenitis suppurativa. Best Pract Res Clin Obstet Gynaecol 28(7):1013\u20131027","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"2040_CR28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jdcr.2016.08.008","volume":"2","author":"K Balighi","year":"2016","unstructured":"Balighi K, Daneshpazhooh M, Azizpour A, Lajevardi V, Mohammadi F, Chams-Davatchi C (2016) Koebner phenomenon in pemphigus vulgaris patients. JAAD Case Rep 2(5):419\u2013421","journal-title":"JAAD Case Rep"},{"issue":"1","key":"2040_CR29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2133.1996.d01-962.x","volume":"135","author":"A Hameed","year":"1996","unstructured":"Hameed A, Khan A (1996) Koebner phenomenon in pemphigus vulgaris. Br J Dermatol 135(1):152\u2013153","journal-title":"Br J Dermatol"},{"issue":"1","key":"2040_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/08820139.2017.1385622","volume":"47","author":"S Li","year":"2018","unstructured":"Li S, Zhang Q, Wang P, Li J, Ni J, Wu J et al (2018) Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Immunol Invest 47(1):101\u2013112","journal-title":"Immunol Invest"},{"issue":"1","key":"2040_CR31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/000155501750208146","volume":"81","author":"J Lapins","year":"2001","unstructured":"Lapins J, Olerup O, Emtestam L (2001) No human leukocyte antigen-A, -B or -DR association in Swedish patients with hidradenitis suppurativa. Acta Derm Venereol 81(1):28\u201330","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"2040_CR32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2340\/00015555-1492","volume":"93","author":"E Mozeika","year":"2013","unstructured":"Mozeika E, Pilmane M, Nurnberg BM, Jemec GB (2013) Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa. Acta Derm Venereol 93(3):301\u2013304","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"2040_CR33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH van der Zee","year":"2011","unstructured":"van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP (2011) Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol 164(6):1292\u20131298","journal-title":"Br J Dermatol"},{"issue":"2","key":"2040_CR34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","volume":"186","author":"K Wolk","year":"2011","unstructured":"Wolk K, Warszawska K, Hoeflich C, Witte E, Schneider-Burrus S, Witte K et al (2011) Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol 186(2):1228\u20131239","journal-title":"J Immunol"},{"issue":"5","key":"2040_CR35","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jaci.2018.01.010","volume":"141","author":"V De Vita","year":"2018","unstructured":"De Vita V, McGonagle D (2018) Hidradenitis suppurativa as an autoinflammatory keratinization disease. J Allergy Clin Immunol 141(5):1953","journal-title":"J Allergy Clin Immunol"},{"key":"2040_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0891","author":"WT Chen","year":"2019","unstructured":"Chen WT, Chi CC (2019) Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol. https:\/\/doi.org\/10.1001\/jamadermatol.2019.0891","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2040_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","volume":"2","author":"S Fimmel","year":"2010","unstructured":"Fimmel S, Zouboulis CC (2010) Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol 2(1):9\u201316","journal-title":"Dermatoendocrinol"},{"issue":"8","key":"2040_CR38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/ijd.13603","volume":"56","author":"C Vinkel","year":"2017","unstructured":"Vinkel C, Thomsen SF (2017) Autoinflammatory syndromes associated with hidradenitis suppurativa and\/or acne. Int J Dermatol 56(8):811\u2013818","journal-title":"Int J Dermatol"},{"key":"2040_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14686","author":"FT Gibson","year":"2019","unstructured":"Gibson FT, Amber KT (2019) Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.14686","journal-title":"Int J Dermatol"},{"issue":"4","key":"2040_CR40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.1976.tb00849.x","volume":"95","author":"RW Gange","year":"1976","unstructured":"Gange RW, Rhodes EL, Edwards CO, Powell ME (1976) Pemphigus induced by rifampicin. Br J Dermatol 95(4):445\u2013448","journal-title":"Br J Dermatol"},{"issue":"6","key":"2040_CR41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2133.1986.tb04882.x","volume":"114","author":"S Miyagawa","year":"1986","unstructured":"Miyagawa S, Yamashina Y, Okuchi T, Konoike Y, Kano T, Sakamoto K (1986) Exacerbation of pemphigus by rifampicin. Br J Dermatol 114(6):729\u2013732","journal-title":"Br J Dermatol"},{"issue":"5","key":"2040_CR42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1540-9740.2004.03343.x","volume":"3","author":"I Goldberg","year":"2004","unstructured":"Goldberg I, Ingher A, Brenner S (2004) Pemphigus vulgaris triggered by rifampin and emotional stress. Skinmed 3(5):294","journal-title":"Skinmed"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-020-02040-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02040-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T21:54:57Z","timestamp":1612821297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-020-02040-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02040-x","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"type":"print","value":"0340-3696"},{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"assertion":[{"value":"2 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.D.C has served as a consultant, advisor or speaker for AbbVie, Amgen, Boehringer Ingelheim, Dexcel pharma, Janssen, Lilly, Neopharm, Novartis, Perrigo, Pfizer and Rafa and has received research grants from Janssen, Novartis, and AbbVie unrelated to this paper. K.K., V.A.J, P.M.P, F.T.G, and K.T.A have no conflicts of interests to declare relevant to this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}